Source:http://linkedlifedata.com/resource/pubmed/id/12899521
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2003-8-5
|
pubmed:abstractText |
The 25-hydroxyvitamin D-1alpha-OHase (1alpha-OHase) is responsible for producing the active form of vitamin D, 1alpha,25-dihydroxyvitamin D. The enzyme not only is expressed in kidneys, but also is expressed in many nonrenal tissues, including skin. In this study, we compared the regulation of the 1alpha-OHase expression in kidney cells and keratinocytes. Using transfected luciferase reporter gene constructs, we compared the activity and regulatory features of the human 1alpha-OHase gene promoter in C-21 human kidney cells (PTH/PTHrP receptor positive) and cultured human keratinocytes (NHKs). We found that two regions, -1,100 bp and -396 bp from the ATG, were highly sensitive to parathyroid hormone (PTH) in C-21 cells but not in NHK. Furthermore, three CRE-like sequences (CLS) were identified within this PTH-sensitive area of the 1alpha-OHase promoter and when deleted they reduced induction of PTH by 50%-95% in C-21 cells. To further investigate the differential regulation profile, we examined the protein products of 1alpha-OHase in kidney and skin. Western blot analysis of whole cell extracts from these tissues with a 1alpha-OHase-specific antibody revealed the predicted 1alpha-OHase protein product of 56 kDa in kidney and a larger protein product of 59 kDa in skin. Using RT-PCR for the 1alpha-OHase in skin and kidney, we detected an insertion between exons 2 and 3 in skin but not in kidney. These results suggest that the regulation of renal and skin 1alpha-OHase gene expression may be tissue specific and possibly produce different splice variants, and that this specificity is likely conferred by differential expression of CRE-binding proteins in different cell types. In conclusion, the differential tissue expression of 1alpha-OHase gene variants and the tissue-specific regulation profile open up a new paradigm in the understanding of the role of 25-hydroxyvitamin D3 1alpha-hydroxylase gene in the regulation of vitamin D physiology.
|
pubmed:grant | |
pubmed:keyword | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0080-0015
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
157-67
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:12899521-25-Hydroxyvitamin D3 1-alpha-Hydroxylase,
pubmed-meshheading:12899521-Alternative Splicing,
pubmed-meshheading:12899521-Animals,
pubmed-meshheading:12899521-Blotting, Western,
pubmed-meshheading:12899521-Cells, Cultured,
pubmed-meshheading:12899521-DNA Primers,
pubmed-meshheading:12899521-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:12899521-Keratinocytes,
pubmed-meshheading:12899521-Kidney,
pubmed-meshheading:12899521-Luciferases,
pubmed-meshheading:12899521-Mice,
pubmed-meshheading:12899521-Mutagenesis, Site-Directed,
pubmed-meshheading:12899521-Promoter Regions, Genetic,
pubmed-meshheading:12899521-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:12899521-Sequence Deletion
|
pubmed:year |
2003
|
pubmed:articleTitle |
Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant.
|
pubmed:affiliation |
Department of Medicine, Endocrine Section, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|